{"title":"Blood product utilisation for coronary artery bypass graft surgery at a public and a private hospital in Western Cape Province, South Africa.","authors":"D Wolmarans, A Bird, C Uys, G M Davison","doi":"10.7196/SAMJ.2021.v111i11.15676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Numerous studies have documented variation in transfusion practice for coronary artery bypass graft (CABG) surgery, despite the widespread availability of clinical guidelines. Blood management systems seek to streamline utilisation, with key indicators being patient care and outcome as well as reduction of waste and cost.</p><p><strong>Objectives: </strong>To facilitate this view, this study sought to audit blood product utilisation for CABG surgery at a private and a public sector hospital in Western Cape Province, South Africa.</p><p><strong>Methods: </strong>A retrospective audit of 100 consecutive patients undergoing CABG surgery at a private and a public hospital during 2017 was performed. Blood product use was compared between the two hospitals, and the influence of confounding factors such as gender, weight, age, pre- and intraoperative medications, type and complexity of the procedure, and patient comorbidities was analysed.</p><p><strong>Results: </strong>The proportion of patients receiving red cell concentrates (RCCs) at the public hospital was significantly higher than at the private hospital (92% v. 56%; p<0.001), which resulted in significantly higher postoperative haemoglobin concentrations (p<0.001). Although the increased proportion of RCC transfusion observed at the public hospital may have been influenced by decreased body mass (p<0.001), the patient population at the private hospital was older (p<0.05) and had higher rates of ischaemia (p<0.001), increased numbers of grafts (p<0.001) and higher preoperative use of aspirin (p<0.05).</p><p><strong>Conclusions: </strong>This study demonstrated increased use of blood products at the public hospital, despite performing fewer grafts. Although this study had limitations, which included low patient numbers and the inclusion of only two hospitals, we concluded that there is a significant variation in the use of blood products despite the risks associated with blood transfusion. These findings could be used to employ systems that will lead to improved blood usage practices.</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"1110-1115"},"PeriodicalIF":1.2000,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7196/SAMJ.2021.v111i11.15676","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Numerous studies have documented variation in transfusion practice for coronary artery bypass graft (CABG) surgery, despite the widespread availability of clinical guidelines. Blood management systems seek to streamline utilisation, with key indicators being patient care and outcome as well as reduction of waste and cost.
Objectives: To facilitate this view, this study sought to audit blood product utilisation for CABG surgery at a private and a public sector hospital in Western Cape Province, South Africa.
Methods: A retrospective audit of 100 consecutive patients undergoing CABG surgery at a private and a public hospital during 2017 was performed. Blood product use was compared between the two hospitals, and the influence of confounding factors such as gender, weight, age, pre- and intraoperative medications, type and complexity of the procedure, and patient comorbidities was analysed.
Results: The proportion of patients receiving red cell concentrates (RCCs) at the public hospital was significantly higher than at the private hospital (92% v. 56%; p<0.001), which resulted in significantly higher postoperative haemoglobin concentrations (p<0.001). Although the increased proportion of RCC transfusion observed at the public hospital may have been influenced by decreased body mass (p<0.001), the patient population at the private hospital was older (p<0.05) and had higher rates of ischaemia (p<0.001), increased numbers of grafts (p<0.001) and higher preoperative use of aspirin (p<0.05).
Conclusions: This study demonstrated increased use of blood products at the public hospital, despite performing fewer grafts. Although this study had limitations, which included low patient numbers and the inclusion of only two hospitals, we concluded that there is a significant variation in the use of blood products despite the risks associated with blood transfusion. These findings could be used to employ systems that will lead to improved blood usage practices.
背景:尽管有广泛的临床指南,但大量研究表明,冠状动脉旁路移植术(CABG)手术中输血实践存在差异。血液管理系统力求简化利用,关键指标是患者护理和结果,以及减少浪费和成本。目的:为了促进这一观点,本研究试图审核南非西开普省一家私立和公立医院CABG手术中血液制品的使用情况。方法:对2017年在一家私立医院和一家公立医院连续行CABG手术的100例患者进行回顾性审计。比较两家医院的血液制品使用情况,并分析混淆因素(如性别、体重、年龄、术前和术中用药、手术类型和复杂性以及患者合并症)的影响。结果:公立医院接受红细胞浓缩(RCCs)的患者比例明显高于私立医院(92% vs . 56%;P<0.001),这导致术后血红蛋白浓度显著升高(P<0.001)。虽然在公立医院观察到的RCC输血比例的增加可能受到体重下降的影响(p<0.001),但私立医院的患者年龄较大(p<0.05),缺血率较高(p<0.001),移植物数量增加(p<0.001),术前阿司匹林使用率较高(p<0.05)。结论:本研究表明,尽管移植物数量减少,但公立医院的血液制品使用量增加。尽管这项研究存在局限性,包括患者数量少,只纳入了两家医院,但我们得出结论,尽管输血存在风险,但血液制品的使用存在显著差异。这些发现可用于采用将导致改善血液使用做法的系统。